Evidence map›Paper›PMID 31236191›Full record

ArticleOxidative medicine and cellular longevity2019

Impaired Mitochondrial Fusion and Oxidative Phosphorylation Triggered by High Glucose Is Mediated by Tom22 in Endothelial Cells.

Yi Zeng, Qi Pan, Xiaoxia Wang, Dongxiao Li, Yajun Lin, Fuli Man, Fei Xiao, Lixin Guo

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 32 citations in OpenAlex.

  1. Sesamin Promotes Diabetic Wound Healing by Inhibiting Ferroptosis via the SIRT1/Keap1/Nrf2 Pathway.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. The Role of Retinal Dysfunction in Myopia Development.Cellular and molecular neurobiology · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Attenuates of NADStem cell research & therapy · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yi ZengPeKing University Fifth School of Clinical Medicine, Beijing, China.
Qi PanPeKing University Fifth School of Clinical Medicine, Beijing, China.
Xiaoxia WangPeKing University Fifth School of Clinical Medicine, Beijing, China.
Dongxiao LiPeKing University Fifth School of Clinical Medicine, Beijing, China.
Yajun LinPeKing University Fifth School of Clinical Medicine, Beijing, China.
Fuli ManDepartment of Endocrinology, Beijing Hospital, National Center of Gerontology, Beijing, China.
Fei XiaoPeKing University Fifth School of Clinical Medicine, Beijing, China.ORCID 0000-0003-2054-901X
Lixin GuoPeKing University Fifth School of Clinical Medicine, Beijing, China.ORCID 0000-0001-6863-1798
Peking University · CNBeijing Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Much evidence demonstrates that mitochondrial dysfunction plays a crucial role in the pathogenesis of vascular complications of diabetes. However, the signaling pathways through which hyperglycemia leads to mitochondrial dysfunction of endothelial cells are not fully understood. Here, we treated human umbilical vein endothelial cells (HUVECs) with high glucose and examined the role of translocase of mitochondrial outer membrane (Tom) 22 on mitochondrial dynamics and cellular function. Impaired Tom22 expression and protein expression of oxidative phosphorylation (OXPHOS) as well as decreased mitochondrial fusion were observed in HUVECs treated with high glucose. The deletion of Tom22 resulted in reduced mitochondrial fusion and ATP production and increased apoptosis in HUVECs. The overexpression of Tom22 restored the balance of mitochondrial dynamics and OXPHOS disrupted by high glucose. Importantly, we found that Tom22 modulates mitochondrial dynamics and OXPHOS by interacting with mitofusin (Mfn) 1. Taken together, our findings demonstrate for the first time that Tom22 is a novel regulator of both mitochondrial dynamics and bioenergetic function and contributes to cell survival following high-glucose exposure.

Indexed as

ApoptosisGene Expression RegulationGlucoseHumansHuman Umbilical Vein Endothelial CellsMembrane Potential, MitochondrialMitochondriaMitochondrial DynamicsMitochondrial Membrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsOxidative PhosphorylationSignal TransductionGlucoseMitochondrial Membrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsTOMM22 protein, human

Identifiers

PMID31236191
PMCPMC6545771
OpenAlexW2945313386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.